GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins November 28, 2024
Displaying entries 29851 - 29900 of 39437 in total
PDB ID ▲ UniProt ID Title Descriptor
7T9J P0DTC2 Cryo-EM structure of the SARS-CoV-2 Omicron spike protein
7T9K P0DTC2 Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
7T9K Q9BYF1 Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2
7T9L P0DTC2 Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
7T9L Q9BYF1 Cryo-EM structure of SARS-CoV-2 Omicron spike protein in complex with human ACE2 (focused refinement of RBD and ACE2)
7T9M 7T9M Human Thyrotropin receptor bound by CS-17 Inverse Agonist Fab/Org 274179-0 Antagonist
7T9M A0A0A0MTJ0 Human Thyrotropin receptor bound by CS-17 Inverse Agonist Fab/Org 274179-0 Antagonist
7T9N 7T9N M22 Agonist Autoantibody bound to Human Thyrotropin receptor in complex with miniGs399 (composite structure)
7T9N A0A0A0MTJ0 M22 Agonist Autoantibody bound to Human Thyrotropin receptor in complex with miniGs399 (composite structure)
7T9N P63092 M22 Agonist Autoantibody bound to Human Thyrotropin receptor in complex with miniGs399 (composite structure)
7T9N P62873 M22 Agonist Autoantibody bound to Human Thyrotropin receptor in complex with miniGs399 (composite structure)
7T9N P59768 M22 Agonist Autoantibody bound to Human Thyrotropin receptor in complex with miniGs399 (composite structure)
7T9T M4M0W3 Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with complex glycans
7T9T Q2N0S5 Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with complex glycans
7T9T 7T9T Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with complex glycans
7TAA P10529 FAMILY 13 ALPHA AMYLASE IN COMPLEX WITH ACARBOSE TAKA AMYLASE
7TAS P0DTC2 SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (local refinement of the RBD and S2K146)
7TAS 7TAS SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (local refinement of the RBD and S2K146)
7TAT P0DTC2 SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-binding domains open)
7TAT 7TAT SARS-CoV-2 spike in complex with the S2K146 neutralizing antibody Fab fragment (two receptor-binding domains open)
7TB4 A0A8A4XEV3 Cryo-EM structure of the spike of SARS-CoV-2 Omicron variant of concern
7TB8 P0DTC2 Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
7TB8 7TB8 Cryo-EM structure of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
7TBB Q2KNW6 Crystal structure of Plasmepsin X from Plasmodium falciparum
7TBC Q2KNW6 Crystal structure of Plasmepsin X from Plasmodium falciparum in complex with WM382
7TBD A0A1G4H6I9 Crystal structure of Plasmepsin X from Plasmodium vivax in complex with WM382
7TBE A0A1G4H6I9 Crystal structure of Plasmepsin X from Plasmodium vivax in complex with WM4
7TBF P0DTC2 Locally refined region of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
7TBF 7TBF Locally refined region of SARS-CoV-2 spike in complex with antibodies B1-182.1 and A19-61.1
7TBW B2RUU2 The structure of ATP-bound ABCA1
7TBY B2RUU2 The structure of human ABCA1 in nanodisc
7TBZ B2RUU2 The structure of ABCA1 Y482C
7TC0 B2RUU2 The structure of human ABCA1 in digitonin
7TC9 P0DTC2 Locally refined region of SARS-CoV-2 spike in complex with antibody A19-46.1
7TC9 7TC9 Locally refined region of SARS-CoV-2 spike in complex with antibody A19-46.1
7TCA P0DTC2 Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1
7TCA 7TCA Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibody A19-46.1
7TCC P0DTC2 Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1
7TCC 7TCC Cryo-EM structure of SARS-CoV-2 Omicron spike in complex with antibodies A19-46.1 and B1-182.1
7TCE Q02761 Crystal structure of delta sub IV Rhodobacter Sphaeroides bc1 with the antimalarial drug atovaquone.
7TCE A3PFR5 Crystal structure of delta sub IV Rhodobacter Sphaeroides bc1 with the antimalarial drug atovaquone.
7TCE Q02762 Crystal structure of delta sub IV Rhodobacter Sphaeroides bc1 with the antimalarial drug atovaquone.
7TCN M4M0W3 Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with high-mannose glycans
7TCN Q2N0S5 Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with high-mannose glycans
7TCN 7TCN Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with high-mannose glycans
7TCO M4M0W3 Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.G458Y.SOSIP.664 with high-mannose glycans
7TCO Q2N0S5 Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.G458Y.SOSIP.664 with high-mannose glycans
7TCO 7TCO Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.G458Y.SOSIP.664 with high-mannose glycans
7TCT P08514 Integrin alaphIIBbeta3 complex with UR2922
7TCT P05106 Integrin alaphIIBbeta3 complex with UR2922

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024